Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules 
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix 
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey 
Bank of Japan Signals Potential Rate Hike as Inflation Risks Rise Amid Energy Shock 
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy 
The four types of dementia most people don’t know exist 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Florida Launches Criminal Probe Into OpenAI Over FSU Shooting Incident 
Japan Inflation Rises in March Amid Energy Price Surge and Middle East Tensions 
USDA Plans to Expand Farmer Surveys to Improve Crop Report Accuracy 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
SK Hynix Reports Record Q1 Profit Surge Driven by AI Memory Chip Demand 
Kubota Pharmaceutical will sell specially designed glasses dubbed Kubota Glass, which it claims are able to reverse the effects of myopia.
The glasses shine tiny lights at the retina to simulate short-distance blurring, forcing the user to look further ahead and in doing so taking the pressure of the axial deformation of eyeballs.
Long-term testing is still required to gauge how effective Kubota Glass is at this in detail, but studies so far suggest that they are at least effective at curbing the progression of myopia.
Kubota Glass has been approved as a medical device in Taiwan and the USA.
Kubota Pharmaceutical charges 770,000 yen for a pair of Kubota Glass while offering a 100-percent satisfaction guarantee.
According to 2009 research conducted by Japan's Ministry of Education, Culture, Sports, Science, and Technology, around 25% of first-graders had less than perfect eyesight, with the percentage rising to 50% among sixth-graders.
